NEUTREXIN PWS IV 25MG/VIAL
NEUTREXIN PWS IV 25MG/VIAL
Discontinued
DIN Number
02065770
Drug Class
Human
Market Date
Dec 31, 1994
Company
HC
MedImmune Oncology, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02065770
AIG Number0125420001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01AX07 TRIMETREXATE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:30.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TRIMETREXATE (TRIMETREXATE GLUCURONATE)Active
Strength: 25 MG / VIAL
Monograph: TRIMETREXATE (TRIMETREXATE GLUCURONATE)